Short Interest in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Decreases By 28.9%

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) saw a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 895,600 shares, a drop of 28.9% from the January 31st total of 1,260,000 shares. Approximately 4.3% of the shares of the company are sold short. Based on an average daily trading volume, of 9,270,000 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Investors Weigh In On FOXO Technologies

A hedge fund recently bought a new stake in FOXO Technologies stock. Jane Street Group LLC bought a new position in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned approximately 0.67% of FOXO Technologies at the end of the most recent quarter. 44.89% of the stock is currently owned by hedge funds and other institutional investors.

FOXO Technologies Stock Performance

NYSEAMERICAN FOXO traded down $0.00 during trading hours on Monday, hitting $0.17. 813,269 shares of the company’s stock traded hands, compared to its average volume of 9,902,046. FOXO Technologies has a 52 week low of $0.13 and a 52 week high of $1.30. The business’s fifty day moving average price is $0.28 and its two-hundred day moving average price is $0.25.

About FOXO Technologies

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.